During their time on campus, recent University of California Santa Cruz graduates Ted Malpass and Edwina Malmberg channeled their passion for health equity issues into undergraduate research. Now, the study they helped to author is published in the peer-reviewed journal, Area Development and Policy, and is shedding new light on how local and national governments deal with the trade-offs between economic benefits and health benefits in their relations with the biopharmaceutical industry.
Combination of therapies presents a new way to treat sleep apnea
Professor Danny Eckert, Director at the Adelaide Institute for Sleep Health: Flinders Health and Medical Research Institute Sleep Health Research Program, says his research team has examined shortcomings in some people’s response to the popular continuous positive airway pressure machine (CPAP) and found that adding combinations of therapies gets impressive results in those who are unable to tolerate CPAP.
Single-dose injectable nanovaccine-in-hydrogel for robust cancer immunotherapy
The present variants of cancer immunotherapy such as immune checkpoint blockades only benefit a small subset of patients due to its immunosuppressive tumor microenvironment. The capacity to vaccinate tumors and reduce immunosuppression in the microenvironment is a significant method to improve cancer immunotherapy.
Proper implementation of CDF will yield desirable results – Rashinda Mulenga
By ROGERS KALERO
A PROPER implementation of the increased Constituency Development Fund (CDF) will yield multiple benefits for various communities and also help to set the stage for poverty alleviation, economic recovery and national development, Rashida Mulenga has said.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
OUR ELECTED LEADERS ARE UNJUST – BISHOP MPUNDU
By NATION REPORTER
EMERITUS Archbishop Telesphore Mpundu has condemned the harsh removal of vendors from the streets in Lusaka, Kabwe and Ndola describing the act as inhuman because most of the people trading on the streets were youths and women without jobs.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
Parallel group craft activities proven effective in occupational therapy
A research team from the Graduate School of Rehabilitation Science at Osaka Metropolitan University investigated the electrophysiological benefits of working in the presence of others from the perspectives of brain and autonomic nervous system activity. The researchers found that parasympathetic activity—which indicates relaxation—was significantly higher when two individuals were working separately than when one individual was working alone.
Treatment strategies for adenoid cystic carcinoma of the head and neck
A new paper was published in Oncoscience on June 28, 2023, entitled, “Adenoid cystic carcinoma of the head and neck—treatment strategies of a highly malignant tumor with variable localizations.”
Pre-transplant microbiome sets the stage for graft-versus-host disease
Bone marrow transplants have saved the lives of thousands of blood cancer patients, but graft-versus-host disease, or GVHD, remains a debilitating and even life-threatening complication. A new study from Fred Hutchinson Cancer Center points to patients’ pre-transplant gut microbiome as a major player in the development and severity of GVHD.
RNA stability may play a role in prostate cancer
Mutations in a genetic region that regulates RNA stability could influence prostate cancer outcomes and drug resistance, according to new work from scientists at Fred Hutchinson Cancer Center published in Cell Reports.
Researchers discover antibody that neutralizes both RSV and human metapneumovirus
Vanderbilt University Medical Center and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).